Parathyroid carcinoma

What changed: Parathyroid carcinoma

Cancer page →

Every dated change on the records linked to Parathyroid carcinoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Approval1Guideline1Milestone5This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-10This recordParathyroid carcinoma
Facts on this page last checked
When this page itself was last checked or edited.

2022 · 1

2022MilestoneParathyroid carcinoma
WHO classification refines carcinoma criteria
Fifth edition endocrine tumours.

2016 · 1

2016GuidelineParathyroid carcinoma
Guideline NCCN Neuroendocrine and Adrenal Tumors (parathyroid carcinoma); American Association of Endocrine Surgeons guideline 2016: Suspected or confirmed carcinoma, resectable
En bloc resection with ipsilateral thyroid lobectomy and removal of adherent tissue, avoiding capsule rupture; re-resection for loco-regional recurrence. (NCCN Category 2A)

2004 · 2

2003 · 1

2003MilestoneParathyroid carcinoma
Somatic and germline CDC73 mutations in sporadic parathyroid carcinoma
Shattuck and colleagues, NEJM.

2002 · 1

2002MilestoneParathyroid carcinoma
HRPT2 (CDC73) identified as the hyperparathyroidism-jaw tumour syndrome gene
Carpten and colleagues, Nat Genet.

1933 · 1

1933MilestoneParathyroid carcinoma
First clear description of parathyroid carcinoma (Sainton and Millot)
A milestone in how this cancer is treated.